Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Tärnvik A[au]:

Tularaemia. Tärnvik A et al. Eur Respir J. (2003)

Editorial--an introduction to the new Infectious Diseases. Tärnvik A et al. Scand J Infect Dis. (2014)

Management of complicated skin and skin structure infections - a call for infectious disease specialists. Tärnvik A et al. Infect Dis (Lond). (2018)

Search results

Items: 1 to 50 of 120

1.

Management of complicated skin and skin structure infections - a call for infectious disease specialists.

Tärnvik A.

Infect Dis (Lond). 2018 Feb;50(2):117-118. doi: 10.1080/23744235.2017.1363405. Epub 2017 Aug 16. No abstract available.

PMID:
28812401
2.

Editorial--an introduction to the new Infectious Diseases.

Tärnvik A, Weiland O.

Scand J Infect Dis. 2014 Dec;46(12):817. doi: 10.3109/00365548.2014.983319. No abstract available.

PMID:
25400099
3.

In memoriam--Professor Ragnar Norrby (1943-2014).

Tärnvik A, Weiland O.

Scand J Infect Dis. 2014 Aug;46(8):545-6. doi: 10.3109/00365548.2014.940699. No abstract available.

PMID:
25023323
4.

Persistence of cell-mediated immunity three decades after vaccination with the live vaccine strain of Francisella tularensis.

Eneslätt K, Rietz C, Rydén P, Stöven S, House RV, Wolfraim LA, Tärnvik A, Sjöstedt A.

Eur J Immunol. 2011 Apr;41(4):974-80. doi: 10.1002/eji.201040923. Epub 2011 Feb 21.

5.
6.

New approaches to diagnosis and therapy of tularemia.

Tärnvik A, Chu MC.

Ann N Y Acad Sci. 2007 Jun;1105:378-404. Epub 2007 Apr 27. Review.

PMID:
17468229
7.

The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages.

Lindgren H, Stenman L, Tärnvik A, Sjöstedt A.

Microbes Infect. 2005 Mar;7(3):467-75. Epub 2005 Feb 26.

PMID:
15788155
8.

[Importance of non-graded student case discussions].

Tärnvik A.

Lakartidningen. 2004 Nov 4;101(45):3620. Swedish. No abstract available.

PMID:
15575434
9.
10.

[The case method--engaging teaching method. Realistic exercises make practical training of the medical profession possible].

Tärnvik A.

Lakartidningen. 2004 Oct 21;101(43):3314-6, 3319. Swedish. No abstract available.

PMID:
15543953
11.

Tularaemia in Europe: an epidemiological overview.

Tärnvik A, Priebe HS, Grunow R.

Scand J Infect Dis. 2004;36(5):350-5. Review.

PMID:
15287379
12.

Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica.

Stenmark S, Lindgren H, Tärnvik A, Sjöstedt A.

Microb Pathog. 2003 Aug;35(2):73-80.

PMID:
12901846
13.

Tularaemia.

Tärnvik A, Berglund L.

Eur Respir J. 2003 Feb;21(2):361-73. Review.

14.
15.
16.

[Alarming tuberculosis situation. Better epidemiologic preparedness is necessary to resist pressure from the surrounding world].

Tärnvik A.

Lakartidningen. 2002 Jun 6;99(23):2616-7. Swedish. No abstract available.

PMID:
12101613
17.

In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.

Johansson A, Urich SK, Chu MC, Sjöstedt A, Tärnvik A.

Scand J Infect Dis. 2002;34(5):327-30.

PMID:
12069013
18.

V gamma 9V delta 2 T cells in human legionellosis.

Kroca M, Johansson A, Sjöstedt A, Tärnvik A.

Clin Diagn Lab Immunol. 2001 Sep;8(5):949-54.

19.

Ciprofloxacin for treatment of tularemia.

Johansson A, Berglund L, Sjöstedt A, Tärnvik A.

Clin Infect Dis. 2001 Jul 15;33(2):267-8. No abstract available.

PMID:
11418893
20.

Long-lasting recall response of CD4+ and CD8+ alphabeta T cells, but not gammadelta T cells, to heat shock proteins of francisella tularensis.

Ericsson M, Kroca M, Johansson T, Sjöstedt A, Tärnvik A.

Scand J Infect Dis. 2001;33(2):145-52.

PMID:
11233852
21.

[Increasing transmission of tuberculosis in the world. Multiresistant strains are the greatest threat].

Tärnvik A.

Lakartidningen. 2000 Nov 29;97(48):5590-2. Swedish. No abstract available.

PMID:
11187373
23.

Ciprofloxacin for treatment of tularemia in children.

Johansson A, Berglund L, Gothefors L, Sjöstedt A, Tärnvik A.

Pediatr Infect Dis J. 2000 May;19(5):449-53.

PMID:
10819342
25.

Serologic evidence of Puumala virus infection in wild moose in northern Sweden.

Ahlm C, Wallin K, Lundkvist A, Elgh F, Juto P, Merza M, Tärnvik A.

Am J Trop Med Hyg. 2000 Jan;62(1):106-11.

PMID:
10761733
26.

Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia.

Johansson A, Berglund L, Eriksson U, Göransson I, Wollin R, Forsman M, Tärnvik A, Sjöstedt A.

J Clin Microbiol. 2000 Jan;38(1):22-6.

27.

Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose.

Wiström J, Ahlm C, Lundberg S, Settergren B, Tärnvik A.

Vaccine. 1999 Apr 23;17(17):2162-5.

PMID:
10367949
28.

[New aspects of the pathogenesis of hantavirus infections. A systemic disease with general vascular changes].

Linderholm M, Sandström T, Tärnvik A.

Lakartidningen. 1999 Apr 28;96(17):2083-6. Review. Swedish. No abstract available.

PMID:
10354671
29.

Development of humoral cross-reactivity to the nucleocapsid protein of heterologous hantaviruses in nephropathia epidemica.

Elgh F, Linderholm M, Wadell G, Tärnvik A, Juto P.

FEMS Immunol Med Microbiol. 1998 Dec;22(4):309-15.

30.

A minority of seropositive wild bank voles (Clethrionomys glareolus) show evidence of current Puumala virus infection.

Alexeyev OA, Ahlm C, Elgh F, Aava B, Palo T, Settergren B, Tärnvik A, Wadell G, Juto P.

Epidemiol Infect. 1998 Oct;121(2):419-25.

31.

[Treatment of tularemia in children].

Berglund L, Gothefors L, Tärnvik A.

Lakartidningen. 1998 Sep 2;95(36):3758. Swedish. No abstract available.

PMID:
9766132
32.

Cryptococcosis and starling nests.

Kumlin U, Olsen B, Granlund M, Elmqvist LG, Tärnvik A.

Lancet. 1998 Apr 18;351(9110):1181. No abstract available.

PMID:
9643699
33.

Prevalence of antibodies specific to Puumala virus among farmers in Sweden.

Ahlm C, Thelin A, Elgh F, Juto P, Stiernström EL, Holmberg S, Tärnvik A.

Scand J Work Environ Health. 1998 Apr;24(2):104-8.

34.

Impaired pulmonary function in patients with hemorrhagic fever with renal syndrome.

Linderholm M, Sandström T, Rinnström O, Groth S, Blomberg A, Tärnvik A.

Clin Infect Dis. 1997 Nov;25(5):1084-9.

PMID:
9402362
35.

Increased plasma levels of soluble CD23 in haemorrhagic fever with renal syndrome; relation to virus-specific IgE.

Alexeyev OA, Linderholm M, Elgh F, Wadell G, Juto P, Tärnvik A.

Clin Exp Immunol. 1997 Aug;109(2):351-5.

36.

High prevalence of hantavirus antibodies in bank voles (Clethrionomys glareolus) captured in the vicinity of households afflicted with nephropathia epidemica.

Ahlm C, Alexeyev OA, Elgh F, Aava B, Wadell G, Tarnvik A, Juto P, Palo T.

Am J Trop Med Hyg. 1997 Jun;56(6):674-8.

PMID:
9230802
37.
38.

Listeria monocytogenes-induced liver abscess in pregnancy.

Lindgren P, Pla JC, Högberg U, Tärnvik A.

Acta Obstet Gynecol Scand. 1997 May;76(5):486-8. No abstract available.

PMID:
9197456
40.

Detection of Francisella tularensis in ulcers of patients with tularemia by PCR.

Sjöstedt A, Eriksson U, Berglund L, Tärnvik A.

J Clin Microbiol. 1997 May;35(5):1045-8.

41.

Infrequent manifestations of tularaemia in Sweden.

Tärnvik A, Sandström G, Sjöstedt A.

Scand J Infect Dis. 1997;29(5):443-6. Review.

PMID:
9435029
42.

Prevalence of serum antibodies to hantaviruses in northern Sweden as measured by recombinant nucleocapsid proteins.

Ahlm C, Juto P, Stegmayr B, Settergren B, Wadell G, Tärnvik A, Elgh F.

Scand J Infect Dis. 1997;29(4):349-54.

PMID:
9360248
43.

CD4 lymphopenia in a patient with cryptococcal osteomyelitis.

Kumlin U, Elmqvist LG, Granlund M, Olsen B, Tärnvik A.

Scand J Infect Dis. 1997;29(2):205-6.

PMID:
9181663
44.

[The body's defense against intracellular bacteria].

Tärnvik A.

Nord Med. 1997 Jan;112(1):10-3. Swedish.

PMID:
9045205
45.
46.

Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis.

Golovliov I, Kuoppa K, Sjöstedt A, Tärnvik A, Sandström G.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):239-44.

PMID:
8861036
47.

Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism.

Tärnvik A, Ericsson M, Golovliov I, Sandström G, Sjöstedt A.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):221-5.

PMID:
8861033
48.

Epidemiological analysis of tularemia in Sweden 1931-1993.

Tärnvik A, Sandström G, Sjöstedt A.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):201-4. No abstract available.

PMID:
8861029
49.

Francisella tularensis: host-parasite interaction.

Sjöstedt A, Tärnvik A, Sandström G.

FEMS Immunol Med Microbiol. 1996 Mar;13(3):181-4. Review. No abstract available.

PMID:
8861025
50.

Supplemental Content

Loading ...
Support Center